Psychiatric Disturbance or Parkinsonism as a Presentation of CNS Lymphoma: Observational Retrospective Study and Review of Literature.
Journal
American journal of clinical oncology
ISSN: 1537-453X
Titre abrégé: Am J Clin Oncol
Pays: United States
ID NLM: 8207754
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
pubmed:
23
7
2020
medline:
5
1
2021
entrez:
23
7
2020
Statut:
ppublish
Résumé
To evaluate the incidence of and characterize the presentation of neuropsychiatric symptoms and/or Parkinsonism as a presentation of central nervous system lymphoma (CNSL) in either its primary CNSL form or when it spreads to the brain in systemic diffuse large B-cell lymphoma (secondary CNSL). With Institutional Review Board approval we identified patients who had been treated at Mayo Clinic from 1998 to 2018 and were recorded to have a combination of ICD 9/10 codes for CNSL and various psychiatric diagnoses. A total of 20 of the 232 patients (9%) were noted to have neuropsychiatric symptoms preceding diagnosis. The average age at diagnosis was 62, with even split for sex. The majority (85%) of patients had primary CNSL. The average duration of symptoms before the diagnosis was 4.8 months. Confusion (80%), depression (40%), apathy (30%), anxiety (30%), and agitation (30%) were the most common symptoms identified. The majority (65%) of patients had subcortical lesions followed by the frontal lobe (50%). Parkinsonism was identified in 5 of the 20 patients with 4 demonstrating resolution of symptoms with treatment of the lymphoma. Neuropsychiatric symptoms are a rare but notable symptom before the presentation of CNSL. There is an increasing awareness of neurological illness presenting as pure psychiatric disturbance, prompting the need to exclude organic and treatable diseases, particularly in elderly patients. Acknowledgment and diagnosis are important for an appropriate management as there is a significant impact on patient and caregiver quality of life.
Identifiants
pubmed: 32694297
doi: 10.1097/COC.0000000000000738
pii: 00000421-202010000-00009
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
727-733Références
Han CH, Batchelor TT. Diagnosis and management of primary central nervous system lymphoma. Cancer. 2017;123:4314–4324.
Nagle SJ, Shah NN, Ganetsky A, et al. Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS. Int J Hematol Oncol. 2017;6:113–121.
Ekenel M, DeAngelis LM. Treatment of primary central nervous system lymphoma. Curr Neurol Neurosci Rep. 2007;7:191–199.
Cosci F, Fava GA, Sonino N. Mood and anxiety disorders as early manifestations of medical illness: a systematic review. Psychother Psychosom. 2015;84:22–29.
Shail MS. Neuropsychiatry in demyelination disease: using depression as a prodrome for early diagnosis and treatment of multiple sclerosis. Cureus. 2017;9:e1813–e1820.
Agarwal PA, Menon S, Smruti BK, et al. Primary central nervous system lymphoma: a profile of 26 cases from Western India. Neurol India. 2009;57:756–763.
Liu W, Xue J, Yu S, et al. Primary central nervous system lymphoma mimicking recurrent depressive disorder: a case report. Oncol Lett. 2015;9:1819–1821.
Fisher R, Harper C. Depressive illness as a presentation of primary lymphoma of the central nervous system. Aust N Z J Psychiatry. 1983;17:84–90.
Filley CM, Kleinschmidt-DeMasters BK. Neurobehavioral presentations of brain neoplasms. West J Med. 1995;163:19–25.
Mihara M, Sugase S, Konaka K, et al. The “pulvinar sign” in a case of paraneoplastic limbic encephalitis associated with non-Hodgkin’s lymphoma. J Neurol Neurosurg Psychiatry. 2005;76:882–884.
Heinrich A, Vogelgesang S, Kirsch M, et al. Intravascular lymphomatosis presenting as rapidly progressive dementia. Eur Neurol. 2005;54:55–58.
Kendall KM, Thomas RH, Corkill RG, et al. A neurological presentation of intravascular B-cell lymphoma. BMJ Case Rep. 2012;2012:bcr2012006439.
Olde Engberink RH, Knippels MC, Pijpers E. Hypomanic episode as a first presentation of a large B-cell lymphoma. Jpn J Clin Oncol. 2013;43:318–320.
Liu C-C, Lin C-C. Diagnosis of primary CNS lymphoma. J Med Sci. 2009;29:155–158.
Fonkem E, Dayawansa S, Stroberg E, et al. Neurological presentations of intravascular lymphoma (IVL): meta-analysis of 654 patients. BMC Neurology. 2016;16:9.
Neto HRS, Cavalcante WCP, Filho SNM, et al. Capgras syndrome associated with limbic encephalitis in a patient with diffuse large B-cell lymphoma. Dement Neuropsychol. 2016;10:63–69.
Ali M, Das S. Psychosis as an indicator of recurrent non-Hodgkin’s lymphoma: a rare presentation. Gen Psychiatr. 2018;31:e000005.
Ospina-García N, Román GC, Pascual B, et al. Hypothalamic relapse of a cardiac large B-cell lymphoma presenting with memory loss, confabulation, alexia-agraphia, apathy, hypersomnia, appetite disturbances and diabetes insipidus. BMJ Case Rep. 2018;2018:bcr2016217700.
Suzuki T, Yamamoto M, Saitoh M, et al. A case of intracranial malignant lymphoma with pure akinesia and repeated regression on CT scans. No To Shinkei [Brain and Nerve]. 1984;36:689–696.
Gherardi R, Roualdes B, Fleury J, et al. Parkinsonian syndrome and central nervous system lymphoma involving the substantia nigra. A case report. Acta Neuropathol. 1985;65:338–343.
Pramstaller PP, Salerno A, Bhatia KP, et al. Primary central nervous system lymphoma presenting with a Parkinsonian syndrome of pure akinesia. J Neurol. 1999;246:934–938.
Haussermann P, Wilhelm T, Keinath S, et al. Primary central nervous system lymphoma in the SMA presenting as rapidly progressive parkinsonism. Mov Disord. 2001;16:962–965.
Sánchez-Guerra M, Cerezal L, Leno C, et al. Primary brain lymphoma presenting as Parkinson’s disease. Neuroradiology. 2001;43:36–40.
Foy J, Primrose W, Mackenzie J. Primary cerebral lymphoma presenting with Parkinsonism. Scott Med J. 2007;52:55–55.
Tan JH, Goh BC, Tambyah PA, et al. Paraneoplastic progressive supranuclear palsy syndrome in a patient with B-cell lymphoma. Parkinsonism Relat Disord. 2005;11:187–191.
Lin CM, Hong K. Cerebral infratentorial large B-cell lymphoma presenting as Parkinsonism. Tohoku J Exp Med. 2010;220:187–190.
Pandit L, Raghotham A, Chickabasaviah Y, et al. Neoplastic Parkinsonism: an illustrative case report. Ann Indian Acad Neurol. 2013;16:437–439.
Herken J, Prüss H. Red flags: clinical signs for identifying autoimmune encephalitis in psychiatric patients. Front Psychiatry. 2017;8:1–9.
Al-Diwani A, Handel A, Townsend L, et al. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry. 2019;6:235–246.
Popescu A, Kao AH. Neuropsychiatric systemic lupus erythematosus. Curr Neuropharmacol. 2011;9:449–457.
Rouchell AM. Major depression in primary care. Ochsner J. 2000;2:79–84.
Griswold KS, Del Regno PA, Berger RC. Recognition and differential diagnosis of psychosis in primary care. Am Fam Physician. 2015;91:856–863.
Gunaydin LA, Kreitzer AC. Cortico–basal ganglia circuit function in psychiatric disease. Annu Rev Physiol. 2016;78:327–350.
Ring HA, Serra-Mestres J. Neuropsychiatry of the basal ganglia. J Neurol Neurosurg Psychiatry. 2002;72:12–21.
Starkstein SE, Robinson RG, Berthier ML, et al. Differential mood changes following basal ganglia vs thalamic lesions. Arch Neurol. 1988;45:725–730.
Lauterbach EC, Harris JB, Bina WF. Mood and neurobehavioral correlates of cerebellar lesions. Cogn Behav Neurol. 2010;23:63–73.
Schutter DJLG, Van Honk J. The cerebellum on the rise in human emotion. Cerebellum. 2005;4:290–294.
Pellicano C, Benincasa D, Pisani V, et al. Prodromal non-motor symptoms of Parkinson’s disease. Neuropsychiatr Dis Treat. 2007;3:145–152.
Foster AR, Caplan JP. Paraneoplastic limbic encephalitis. Psychosomatics. 2009;50:108–113.
Carr I. The Ophelia syndrome: memory loss in Hodgkin’s disease. Lancet. 1982;1:844–845.
Rooney A, Grant R. Pharmacological treatment of depression in patients with a primary brain tumour. Cochrane Database Syst Rev. 2013;5:CD006932.